ArticleApplied microbiology and biotechnology2016

A phase trial of the oral Lactobacillus casei vaccine polarizes Th2 cell immunity against transmissible gastroenteritis coronavirus infection.

Xinpeng Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.